Cargando…
Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?
γ-Secretase inhibitors are new anti-cancer agents targeting Notch signaling. Their specificity for Notch is as yet unclear. Han and colleagues investigated the effects of Z-LeuLeuNleu-CHO on growth of breast cancer cells. The results demonstrated a reduction in cell viability primarily via proteasom...
Autores principales: | Clementz, Anthony G, Osipo, Clodia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790851/ https://www.ncbi.nlm.nih.gov/pubmed/19849815 http://dx.doi.org/10.1186/bcr2407 |
Ejemplares similares
-
Gamma secretase inhibitors of Notch signaling
por: Olsauskas-Kuprys, Roma, et al.
Publicado: (2013) -
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
por: Clementz, Anthony G, et al.
Publicado: (2011) -
γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets
por: Dorneburg, Carmen, et al.
Publicado: (2016) -
Trastuzumab Resistance: Role for Notch Signaling
por: Mehta, Kinnari, et al.
Publicado: (2009) -
The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition
por: Han, Jianxun, et al.
Publicado: (2009)